xanthomicrol has been researched along with Prostatic Neoplasms in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Almahmoud, S; Elix, CC; Hopkins, CR; Jones, JO; Vennerstrom, JL; Zhong, HA | 1 |
1 other study(ies) available for xanthomicrol and Prostatic Neoplasms
| Article | Year |
|---|---|
Virtual screening and biological evaluation of PPARĪ³ antagonists as potential anti-prostate cancer agents.
Topics: Antineoplastic Agents; Cell Proliferation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Screening Assays, Antitumor; Humans; Male; Molecular Structure; PPAR gamma; Prostatic Neoplasms; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |